CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the U...
Clorox Shakeup and NextCure Merger Underscore Mid-2026 Corporate Overhauls
Ripping Up the Playbook: The Radical Strategic Pivots Reshaping the Market
CorMedix (NASDAQ:CRMD) Stock Price Down 5.9% - Time to Sell?
CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Analysts
The Market’s Misfit Toys: AI Delusions and Quiet Cash Cows
As Q2 earnings kick off, these small-cap stocks earn an A+ for profitability